Methylphenidate’s (2mg/kg/day) pro-cognitive effects weaken with repeated use, in rats; prevention by Buspirone, the 5-HT1A receptor agonist (2015)

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website,

View all posts by Robert Zinn →